Modulation of ERK and JNK activity by transient forebrain ischemia in rats

Journal of Neuroscience Research

Volumn 83, Issue 3, 2006, Pages 476-488

  Shackelford, Deborah A ^a   Yeh, Richard Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c Jun N terminal kinase; Cerebral ischemia; Extracellular signal regulated kinase; MAP kinase; Reperfusion

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL DEATH; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; FOREBRAIN; HIPPOCAMPUS; MOUSE; NEOCORTEX; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CYTOSOL; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; ISCHEMIC ATTACK, TRANSIENT; MAP KINASE KINASE 4; NEURONS; PHOSPHORYLATION; PROSENCEPHALON; RATS; RATS, WISTAR; REPERFUSION; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 31844447556     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20747     Document Type: Article

References (61)

1. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. 1999. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A 96:12866-12869.
2. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR. 2003. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5:647-653.
3. Behrens M, Strasser U, Lobner D, Dugan L. 1999. Neurotrophin-mediated potentiation of neuronal injury. Microsc Res Techniq 45:276-284.
4. Borsello T, Clarke PGH, Hirt L, Vercelli A, Repici M, Schorderet D, Bogousslavsky J, Bonny C. 2003. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral isachemia. Nat Med 9:1180-1186.
5. Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz N, Claussen M, Pearse D, Kuan C-Y, Vaudano E, Behrens A, Wagner E, Flavell RA, Davis RJ, Herdegen T. 2005. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 21:363-377.
6. Bruckner S, Tammariello S, Kuan C-Y, Flavell RA, Rakic P, Estus S. 2001. JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympatheic neurons. J Neurochem 78:298-303.
7. Calabresi P, Centonze D, Pisani A, Cupini LM, Bernardi G. 2003. Synaptic plasticity in the ischaemic brain. Lancet Neurol 2:622-629.
8. 2-terminal protein kinase inhibitor with neuroprotecrive properties. J Pharmacol Exp Ther 310:25-32.
9. Carboni S, Antonsson B, Gaillard P, Gotteland J, Gillon J, Vitte P. 2005. Control of death receptor and mitochrondrial-dependent apoptosis by c-Jun N-terminal kinase in hippcampal CA1 neurones following global transient ischaemia. J Neurochem 92:1054-1060.
10. Castro-Obregon S, Rao R, del Rio G, Chen S, Poksay K, Rabizadeh S, Vesce S, Zhang X, Swanson RA, Bredesen DE. 2004. Alternative, nonapoptotic programmed cell death. J Biol Chem 279:17543-17553.
11. Cavanagh J. 2004. Role of extracellular signal regulated kinase 5 in neuronal survival. Eur J Biochem 271:2056-2059.
12. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
13. Chang L, Jones Y, Ellisman M, Goldstein L, Karin M. 2003. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 4:521-533.
14. Chu C, Levinthal D, Kulich S, Chalovich E, DeFranco DB. 2004. Oxidative neuronal injury: the dark side of ERK 1/2. Eur J Biochem 271: 2060-2066.
15. Clausen F, Lundqvist H, Ekmark S, Lewen A, Ebendal T, Hillered L. 2004. Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apoptosis-like cell death after traumatic brain injury. J Neurotrauma 21:1168-1182.
16. Dan I, Watanabe N, Kusumi A. 2001. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11:220-230.
17. Davis R. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
18. Gao Y, Sigmore A, Yin W, Cao G, Yin X-M, Sun F, Luo Y, Graham SH, Chen J. 2005. Neuroprotection against focal ischemia brain injury by inhibition of c-Jun N-terminal kinase and attenuation of mitochondrial apoptosis-signaling pathway. J Cereb Blood Flow Metab 25:694-712.
19. Graham SH, Chen J. 2001. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21:99-109.
20. Gu Z, Jiang Q, Zhang G. 2001a. c-Jun N-terminal kinase activation in hippocampal CA1 region was involved in ischemic injury. Mol Neurosci 12:897-900.
21. Gu Z, Jiang Q, Zhang G. 2001b. Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death. Brain Res 901:79-84.
22. Guan Q-H, Pei D-S, Zhang Q-G, Hao Z-B, Xu T-L, Zhang G-Y. 2005. The neuroprotective action of SP600125, a new inhibitor of JNK on transient brain ischemia/reperfusion neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways. Brain Res 1035: 51-59.
23. Hetman M, Gozdz A. 2004. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050-2055.
24. Hibi M, Lin A, Smeal T, Minden A, Karin M. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-2148.
25. Hsu M, Buzsáki G. 1993. Vulnerability of mossy fiber targets in the rat hippocampus to forebrain ischemia. J Neurosci 13:3964-3979.
26. Irving EA, Bamford M. 2002. Role of mitogen-and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
27. Kuan C-Y, Yang DD, Roy DRS, Davis RJ, Rakic P, Flavell RA. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22:667-676.
28. Kuan C-Y, Whitnarsh A, Yang DD, Lioa G, Schloemer A, Dong C, Bao J, Banasiak K, Haddad GG, Flavell RA, Davis R, Rakic P. 2003. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci U S A 100:15184-15189.
29. 2-terminal kinase. Mol Cell Biochem 4929-4942.
30. Lin A. 2002. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25:17-24.
31. Liu J, Lin A. 2005. Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15:36-42.
32. Lobner D, Liot G. 2004. Role of MAPK/ERK neurotropin-4 potentiation of necrotic neuronal death. Neurochem Res 29:2303-2309.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with Folin phenol reagent. J Biol Chem 193:265-272.
34. MacManus JP, Buchan AM. 2000. Apoptosis after experimental stroke; fact or fashion? J Neurotrauma 17:899-914.
35. Mielke K, Herdegen T. 2000. JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61:45-60.
36. Mori T, Wang X, Aoki T, Lo EH. 2001a. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma 19:1411-1419.
37. Mori T, Wang X, Jung JC, Sumii T, Singhal A, Fini ME, Dixon CE, Alessandrini A, Lo EH. 2002b. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vitro effects. J Cereb Blood Flow Metab 22:444-452.
38. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A. 2001. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A 98:11569-11574.
39. Noshita N, Sugawara T, Hayashi T, Lewen A, Omar G, Chan PH. 2002. Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 22:7923-7930.
40. Nozaki K, Nishimura M, Hashimoto N. 2001. Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol 23:1-19.
41. Okuno S, Saito A, Hayashi T, Chan PH. 2004. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci 24:7879-7887.
42. Pulsinelli WA, Brierley JB. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272.
43. Pulsinelli WA, Duffy TE. 1983. Regional energy balance in rat brain after transient forebrain ischemia. J Neurochem 40:1500-1503.
44. Pulsinelli WA, Brierley JB, Plum F. 1982a. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498.
45. Pulsinelli WA, Levy DE, Duffy TE. 1982b. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann Neurol 11:500-509.
46. Putcha G, Le S, Frank S, Besirli C, Clark K, Chu B, Alix S, Youle R, LeMarche A, Maroney A, Johnson E Jr. 2003. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptsis. Neuron 38:899-914.
47. Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF. 1999. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89:115-124.
48. 2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochem Res 24:669-677.
49. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
50. Shackelford DA. 1997. Detection of protein kinase activity after renaturation of proteins in SDS-polyacrylamide gels or on membranes. In: Celis JE, editor. Cell biology: a laboratory handbook, vol 4. San Diego: Academic Press, p 466-473.
51. Shackelford DA, Yeh RY. 2001. Differential effects of ischemia and reperfusion on c-Jun N-terminal kinase isoform protein and activity. Brain Res Mol Brain Res 94:178-192.
52. 2+/calmodulin-dependent protein kinase II following spinal cord ischemia. J Neurochem 61:738-747.
53. Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, Narasimham P, Maier CM, Chan P. 2004. Neuronal death/survival signaling pthways in cerebral ischemia. Neuro Rx 1:17-25.
54. Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E. 2000. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci 20:4506-4514.
55. Tian H, Zhang G, Li H, Zhang Q. 2003. Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus. Neurosci Res 46:191-197.
56. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874.
57. Wang R, Zhang Q-Q, Zhang G-Y. 2004. Activation of ERK5 is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated calcium channel via Src involving oxidative stress after cerebral ischemia in rat hippocampus. Neurosci Lett 357:13-16.
58. Wang X, Wang H, Xu L, Rozanski J, Sugawara T, Chan PH, Trazskos JM, Feuerstein GZ. 2003. Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J Pharmacol Exp Ther 304:172-178.
59. Wang Z-Q, Wu D-C, Huang F-P, Yang G-Y. 2004. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996:55-66.
60. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
61. Yang DD, Kuan C-Y, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865-870.